Gene · 10404
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diversity of Bacteria with Quorum Sensing and Quenching Activities from Hydrothermal Vents in the Okinawa Trough. | Microorganisms | 2023 | 36985321 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection. | Microorganisms | 2023 | 36985188 | PubTator, text mining | PubMed |
| The Role of the Ectopeptidase APN/CD13 in Cancer. | Biomedicines | 2023 | 36979703 | PubTator, text mining | PubMed |
| Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases. | Antibiotics (Basel) | 2023 | 36978399 | PubTator, text mining | PubMed |
| Bariatric Surgery and Psychological Health: A Randomised Clinical Trial in Patients with Obesity and Type 2 Diabetes. | Obes Surg | 2023 | 36964319 | PubTator, text mining | PubMed |
| The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease. | J Vet Intern Med | 2023 | 36951394 | PubTator, text mining | PubMed |
| Multiplex substrate profiling by mass spectrometry for proteases. | Methods Enzymol | 2023 | 36948708 | PubTator, text mining | PubMed |
| Characterization of serum and tissue oxytocinase and tissue oxytocin in the pregnant and non-pregnant mare. | Sci Rep | 2023 | 36944665 | PubTator, text mining | PubMed |
| Comparative antihyperglycemic, analgesic and anti-inflammatory potential of ethanolic aerial root extracts of Ceriops decandra and Ceriops tagal: Supported by molecular docking and ADMET analysis. | Heliyon | 2023 | 36938384 | PubTator, text mining | PubMed |
| The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 36930113 | PubTator, text mining | PubMed |
| LTA4H extensively associates with mRNAs and lncRNAs indicative of its novel regulatory targets. | PeerJ | 2023 | 36923505 | PubTator, text mining | PubMed |
| Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy. | Materials (Basel) | 2023 | 36902927 | PubTator, text mining | PubMed |
| Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. | J Exp Clin Cancer Res | 2023 | 36899389 | PubTator, text mining | PubMed |
| Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. | BMJ Open | 2023 | 36898743 | PubTator, text mining | PubMed |
| Unusual peptide-binding proteins guide pyrroloindoline alkaloid formation in crocagin biosynthesis. | Nat Chem | 2023 | 36894702 | PubTator, text mining | PubMed |
| Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis. | Biochem Biophys Rep | 2023 | 36875797 | PubTator, text mining | PubMed |
| Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? | Acta Pharm Sin B | 2023 | 36873165 | PubTator, text mining | PubMed |
| Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity. | Bioorg Chem | 2023 | 36863075 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Enlightening the Path to Protein Engineering: Chemoselective Turn-On Probes for High-Throughput Screening of Enzymatic Activity. | Chem Rev | 2023 | 36853077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10404/papers?page=12